Newsfeeds - Spark Newswire

1 minute read

Analyst Ratings

Expert Ratings For Illumina

Today, 4:51 PM

Over the past 3 months, 5 analysts have published their opinion on Illumina (NASDAQ:ILMN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

ILMN

3 minute read

The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly’s Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO

By Shanthi Rexaline

Today, 4:51 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

BIO

2 minute read

A Peek Into The Markets: US Stock Futures Down Following Thursday’s Plunge

By Lisa Levin

Today, 4:51 PM

Pre-open movers

EXPE

1 minute read

Illumina’s Q4 Profit Falls Despite Topline Growth Of 26%

By Vandana Singh

Today, 4:51 PM

Illumina Inc (NASDAQ: ILMN) reported

ILMN

1 minute read

SVB Leerink Maintains Market Perform on Illumina, Lowers Price Target to $400

By Benzinga Newsdesk

Today, 4:51 PM

SVB Leerink analyst Puneet Souda maintains Illumina (NASDAQ:ILMN) with a Market Perform and lowers the price target from $430 to $400.

ILMN

1 minute read

5 Stocks To Watch For February 11, 2022

By Lisa Levin

Today, 4:51 PM

Some of the stocks that may grab investor focus today are:

EXPE

1 minute read

Earnings

Illumina: Q4 Earnings Insights

By Benzinga Insights

Today, 4:51 PM

Illumina (NASDAQ:ILMN) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Illumina beat estimated earnings by 53.06%, reporting an EPS of $0.75 versus an estimate of $0.49.

ILMN

4 minute read

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly

By Shanthi Rexaline

Today, 4:51 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

AGLE

11 minute read

Earnings Scheduled For February 10, 2022

By Benzinga Insights

Today, 4:51 PM

Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.

ACB

4 minute read

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More

By Shanthi Rexaline

Today, 4:51 PM

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big pharma earnings. The sector came back up in the final session for a firm finish.

ABBV